Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The human inflammatory response

J H Levy1

  • 1Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia, USA.

Journal of Cardiovascular Pharmacology
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incorporating the concept of overtransfusion into hemovigilance monitoring: An expert-based definition and criteria from the International HIT-OVER Forum.

Transfusion·2024
Same author

Differential diagnoses for sepsis-induced disseminated intravascular coagulation: communication from the SSC of the ISTH.

Journal of thrombosis and haemostasis : JTH·2019
Same author

Derangement of the endothelial glycocalyx in sepsis.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Sugammadex hypersensitivity and underlying mechanisms: a randomised study of healthy non-anaesthetised volunteers.

British journal of anaesthesia·2018
Same author

Use of factor concentrates for the management of perioperative bleeding: reply.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Supplementary fibrinogen in the management of bleeding: re-evaluation of data from clinical trials.

British journal of anaesthesia·2018
Same journal

Integration of Mendelian Randomization and FAERS Database Analysis Reveals the Association Between Ergotamine and Aortic and Mitral Valve Diseases.

Journal of cardiovascular pharmacology·2026
Same journal

A Comprehensive Review of PCSK9 Inhibitor Therapy.

Journal of cardiovascular pharmacology·2026
Same journal

SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

Journal of cardiovascular pharmacology·2026
Same journal

Aspirin in primary prevention: a case for selective use.

Journal of cardiovascular pharmacology·2026
Same journal

GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease Treatment.

Journal of cardiovascular pharmacology·2026
Same journal

Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

Journal of cardiovascular pharmacology·2026
See all related articles

Inflammation is a key immune response, but can be overactive. Anaphylaxis, a severe reaction, involves immunoglobulin E or G antibodies and highlights the need for agents to halt inflammatory cascades.

Area of Science:

  • Immunology
  • Pathophysiology
  • Pharmacology

Background:

  • Inflammation is a vital host defense mechanism against injury and pathogens.
  • Exaggerated inflammatory responses, often amplified by immune system components, can cause significant tissue damage.
  • Anaphylaxis serves as a model for acute inflammation, involving complex interactions between cardiovascular, endothelial, and coagulation systems.

Purpose of the Study:

  • To explore the mechanisms of acute inflammation and anaphylaxis.
  • To understand the roles of different immune components and mediators in inflammatory responses.
  • To identify potential therapeutic targets for controlling exaggerated inflammation.

Main Methods:

  • Review of inflammatory pathways and mediators.

Related Experiment Videos

  • Analysis of anaphylaxis as a model for acute inflammation.
  • Discussion of immunoglobulin E and G antibody roles in immune activation.
  • Main Results:

    • Inflammation involves activated macrophages producing cytokines and adhesion molecules.
    • Polymorphonuclear leukocytes are central to acute inflammation.
    • Anaphylaxis can be mediated by immunoglobulin E (IgE) or immunoglobulin G (IgG), activating mast cells or complement (C5a), respectively.

    Conclusions:

    • Understanding the diverse amplifying pathways and mediators in anaphylaxis is crucial for therapeutic strategies.
    • Protamine sulfate can trigger severe anaphylaxis via IgE or IgG pathways.
    • Future research should focus on identifying pharmacologic agents to arrest the inflammatory cascade and prevent host injury.